Advertisement
Screener

Agile Therapeutics, Inc. Form D

Agile Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2014-05-09: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2014-04-28; Total offering amount $3,000,000.
  • 2010-05-05: Federal exemption Rule 506; Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2010-04-21; Total offering amount $1,463,806.
  • 2010-01-12: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2009-12-30; Total offering amount $2,000,000.
  • 2009-10-28: Federal exemption Rule 506; Types of securities offered Equity; Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2009-10-13; Total offering amount $1,081,128.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2014-05-09Rule 506(b)Debt; OptionToAcquire; SecurityToBeAcquired2014-04-28$3,000,000$3,000,000$09
2010-05-05Rule 506Debt; OptionToAcquire; SecurityToBeAcquired2010-04-21$1,463,806$989,178$474,6286
2010-01-12Rule 506Equity; OptionToAcquire; SecurityToBeAcquired2009-12-30$2,000,000$1,010,822$989,17814
2009-10-28Rule 506Equity; Debt; OptionToAcquire; SecurityToBeAcquired2009-10-13$1,081,128$1,005,000$76,12811